- Home
- CASI vs SGRP Comparison
CASI vs SGRP Comparison
Compare CASI & SGRP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CASI
- SGRP
- Stock Information
- Founded
- CASI 1991
- SGRP 1967
- Country
- CASI China
- SGRP United States
- Employees
- CASI N/A
- SGRP N/A
- Industry
- CASI Biotechnology: Pharmaceutical Preparations
- SGRP Business Services
- Sector
- CASI Health Care
- SGRP Consumer Discretionary
- Exchange
- CASI Nasdaq
- SGRP Nasdaq
- Market Cap
- CASI 29.7M
- SGRP 25.2M
- IPO Year
- CASI 1996
- SGRP 1996
- Fundamental
- Price
- CASI $1.89
- SGRP $1.04
- Analyst Decision
- CASI Strong Buy
- SGRP
- Analyst Count
- CASI 1
- SGRP 0
- Target Price
- CASI $4.00
- SGRP N/A
- AVG Volume (30 Days)
- CASI 7.1K
- SGRP 69.9K
- Earning Date
- CASI 05-16-2025
- SGRP 06-10-2025
- Dividend Yield
- CASI N/A
- SGRP N/A
- EPS Growth
- CASI N/A
- SGRP N/A
- EPS
- CASI N/A
- SGRP N/A
- Revenue
- CASI $31,368,000.00
- SGRP $196,814,000.00
- Revenue This Year
- CASI N/A
- SGRP N/A
- Revenue Next Year
- CASI N/A
- SGRP N/A
- P/E Ratio
- CASI N/A
- SGRP N/A
- Revenue Growth
- CASI 8.39
- SGRP N/A
- 52 Week Low
- CASI $1.64
- SGRP $1.00
- 52 Week High
- CASI $7.67
- SGRP $3.12
- Technical
- Relative Strength Index (RSI)
- CASI 47.25
- SGRP 38.90
- Support Level
- CASI $1.77
- SGRP $1.00
- Resistance Level
- CASI $1.98
- SGRP $1.21
- Average True Range (ATR)
- CASI 0.10
- SGRP 0.05
- MACD
- CASI 0.01
- SGRP -0.00
- Stochastic Oscillator
- CASI 54.55
- SGRP 16.67
About CASI CASI Pharmaceuticals Inc.
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.
About SGRP SPAR Group Inc.
SPAR Group Inc is a supplier of merchandising and other marketing services. It also provides range of services to retailers, consumer goods manufacturers and distributors around the globe. The company divides its operations into three reportable regional segments: Americas, which is comprised of United States, Canada, Brazil and Mexico; Asia-Pacific (APAC), which is comprised of Japan, China, and India; and Europe, Middle East and Africa (EMEA), which is comprised of South Africa. It generates maximum revenue from Americas.